Shaping the future of oral cancer diagnosis: advances in salivary proteomics

References

• Julian RS, Woo BM, Rabey EC. Oral Cavity and Oropharyngeal Cancer: Etiology, Diagnosis and Staging. J California Dental Association. 2021;49(3):163–170. doi: 10.1080/19424396.2021.12222685
   Google Scholar
• Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884–11894.
   PubMed Web of Science ®Google Scholar
• Michalke B, Rossbach B, Göen T, et al. Saliva as a matrix for human biomonitoring in occupational and environmental medicine. Int Arch Occup Environ Health. 2015;88(1):1–44. doi: 10.1007/s00420-014-0938-5
   PubMed Web of Science ®Google Scholar
• Rao PV, Reddy AP, Lu X, et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res. 2009;8(1):239–245. doi: 10.1021/pr8003776
   PubMed Web of Science ®Google Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011;57(5):675–687. doi: 10.1373/clinchem.2010.153767
   PubMed Web of Science ®Google Scholar
• Scarano E, Fiorita A, Picciotti PM, et al. Proteomics of saliva: personal experience. Acta Otorhinolaryngol Ital. 2010;30(3):125–130.
   PubMed Web of Science ®Google Scholar
• Castagnola M, Picciotti PM, Messana I, et al. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital. 2011;31(6):347–357.
   PubMed Web of Science ®Google Scholar
• Laine M, Pienihakkinen K, Leimola-Virtanen R. The effect of repeated sampling on paraffin-stimulated salivary flow rates in menopausal women. Arch Oral Biol. 1999;44(1):93–95. doi: 10.1016/S0003-9969(98)00097-1
   PubMed Web of Science ®Google Scholar
• Topkas E, Keith P, Dimeski G, et al. Evaluation of saliva collection devices for the analysis of proteins. Clin Chim Acta. 2012;413(13–14):1066–1070. doi: 10.1016/j.cca.2012.02.020
   PubMed Web of Science ®Google Scholar
• Amado F, Lobo MJ, Domingues P, et al. Salivary peptidomics. Expert Rev Proteomics. 2010;7(5):709–721. doi: 10.1586/epr.10.48
   PubMed Web of Science ®Google Scholar
• Granger DA, Kivlighan KT, Fortunato C, et al. Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Physiol Behav. 2007;92(4):583–590. doi: 10.1016/j.physbeh.2007.05.004
   PubMed Web of Science ®Google Scholar
• Ferguson DB. Current diagnostic uses of saliva. J Dent Res. 1987;66(2):420–424. doi: 10.1177/00220345870660020601
   PubMed Web of Science ®Google Scholar
• Khurshid Z, Zohaib S, Najeeb S, et al. Human saliva collection devices for proteomics: an update. Int J Mol Sci. 2016;17(6):846. doi: 10.3390/ijms17060846
   PubMed Web of Science ®Google Scholar
• Bellagambi FG, Lomonaco T, Salvo P, et al. Saliva sampling: methods and devices. An overview. Trends Analyt Chem. 2020;124:115781. doi: 10.1016/j.trac.2019.115781
   Web of Science ®Google Scholar
• Baum BJ. Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res. 1981;60(7):1292–1296. doi: 10.1177/00220345810600070101
   PubMed Web of Science ®Google Scholar
• Khurshid Z, Moin SF, Khan RS, et al. Human salivary protein extraction from RNAPro.SAL, Pure.SAL, and passive drooling method. Eur J Dent. 2017;11(3):385–389. doi: 10.4103/ejd.ejd_183_17
   PubMedGoogle Scholar
• Heinzerling CI, Stieger M, Bult JH, et al. Individually modified saliva delivery changes the perceived intensity of saltiness and sourness. Chem Percept. 2011;4(4):145–153. doi: 10.1007/s12078-011-9099-z
   PubMed Web of Science ®Google Scholar
• Henson BS, Wong DT. Collection, storage, and processing of saliva samples for downstream molecular applications. Methods Mol Biol. 2010;666:21–30.
   PubMedGoogle Scholar
• Chevalier F, Hirtz C, Chay S, et al. Proteomic studies of saliva: a proposal for a standardized handling of clinical samples. Clin Proteomics. 2007;3(1–4):13–21. doi: 10.1007/s12014-007-9000-x
   Web of Science ®Google Scholar
• Schipper RG, Silletti E, Vingerhoeds MH. Saliva as research material: biochemical, physicochemical and practical aspects. Arch Oral Biol. 2007;52(12):1114–1135. doi: 10.1016/j.archoralbio.2007.06.009
   PubMed Web of Science ®Google Scholar
• Chiang SH, Thomas GA, Liao W, et al. Rnapro*sal: a device for rapid and standardized collection of saliva RNA and proteins. Biotechniques. 2015;58(2):69–76. doi: 10.2144/000114254
   PubMed Web of Science ®Google Scholar
• Xiao H, Wong DT. Method development for proteome stabilization in human saliva. Anal Chim Acta. 2012;722:63–69. doi: 10.1016/j.aca.2012.02.017
   PubMed Web of Science ®Google Scholar
• Esser D, Alvarez-Llamas G, de Vries MP, et al. Sample stability and protein composition of saliva: implications for its use as a diagnostic fluid. Biomark Insights. 2008;3:25–27. doi: 10.4137/BMI.S607
   PubMedGoogle Scholar
• Janardhanam SB, Zunt SL, Srinivasan M. Quality assessment of saliva bank samples. Biopreserv Biobank. 2012;10(3):282–287. doi: 10.1089/bio.2011.0039
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Fukutomi T, Tomonaga T, et al. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples. J Proteome Res. 2010;9(4):1694–1705. doi: 10.1021/pr9008018
   PubMed Web of Science ®Google Scholar
• Carrillo-Rodriguez P, Selheim F, Hernandez-Valladares M. Mass spectrometry-based proteomics workflows in cancer research: the relevance of choosing the right steps. Cancers (Basel). 2023;15(2):555. doi: 10.3390/cancers15020555
   PubMed Web of Science ®Google Scholar
• Brunelle JL, Green R. One-dimensional SDS-polyacrylamide gel electrophoresis (1D SDS-PAGE). Methods Enzymol. 2014;541:151–159.
   PubMed Web of Science ®Google Scholar
• Magdeldin S, Enany S, Yoshida Y, et al. Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis. Clin Proteomics. 2014;11(1):16. doi: 10.1186/1559-0275-11-16
   PubMedGoogle Scholar
• Arentz G, Weiland F, Oehler MK, et al. State of the art of 2D DIGE. Proteomics Clin Appl. 2015;9(3–4):277–288. doi: 10.1002/prca.201400119
   PubMed Web of Science ®Google Scholar
• Shi Y, Xiang R, Horvath C, et al. The role of liquid chromatography in proteomics. J Chromatogr A. 2004;1053(1–2):27–36. doi: 10.1016/S0021-9673(04)01204-X
   PubMed Web of Science ®Google Scholar
• Banerjee S, Mazumdar S. Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte. Int J Anal Chem. 2012;2012:282574. doi: 10.1155/2012/282574
   PubMed Web of Science ®Google Scholar
• Li D, Yi J, Han G, et al. MALDI-TOF mass spectrometry in clinical analysis and research. ACS Meas Sci Au. 2022;2(5):385–404. doi: 10.1021/acsmeasuresciau.2c00019
   PubMedGoogle Scholar
• Neagu AN, Jayathirtha M, Baxter E, et al. Applications of Tandem Mass Spectrometry (MS/MS) in protein analysis for biomedical research. Molecules. 2022;27(8):2411. doi: 10.3390/molecules27082411
   PubMed Web of Science ®Google Scholar
• Carnielli CM, Macedo CCS, De Rossi T, et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat Commun. 2018;9(1):3598. doi: 10.1038/s41467-018-05696-2
   PubMedGoogle Scholar
• Birhanu AG. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories. Clin Proteomics. 2023;20(1):32. doi: 10.1186/s12014-023-09424-x
   PubMed Web of Science ®Google Scholar
• Lou R, Shui W. Acquisition and analysis of DIA-Based proteomic data: a comprehensive survey in 2023. Mol Cell Proteomics. 2024;23(2):100712. doi: 10.1016/j.mcpro.2024.100712
   PubMedGoogle Scholar
• Murray KK, Boyd RK, Eberlin MN, et al. Definitions of terms relating to mass spectrometry (IUPAC recommendations 2013). Pure Appl Chem. 2013;85(7):1515–1609. doi: 10.1351/PAC-REC-06-04-06
   Web of Science ®Google Scholar
• Kooren JA, Rhodus NL, Tang C, et al. Evaluating the potential of a novel oral lesion exudate collection method coupled with mass spectrometry-based proteomics for oral cancer biomarker discovery. Clin Proteomics. 2011;8(1):13. doi: 10.1186/1559-0275-8-13
   PubMedGoogle Scholar
• Alhendi AS. A review: protein identification by LC-MS: principles, instrumentation, and applications. Iraqi J Sci. 2020;61(10):2448–2466. doi: 10.24996/ijs.2020.61.10.2
   Google Scholar
• Chang CY, Picotti P, Huttenhain R, et al. Protein significance analysis in selected reaction monitoring (SRM) measurements. Mol Cell Proteomics. 2012;11(4):M111 014662. doi: 10.1074/mcp.M111.014662
   PubMed Web of Science ®Google Scholar
• Duncan MW, Yergey AL, Patterson SD. Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem. Proteomics. 2009;9(5):1124–1127. doi: 10.1002/pmic.200800739
   PubMed Web of Science ®Google Scholar
• Unwin RD, Griffiths JR, Whetton AD. Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC–MS/MS. Nat Protoc. 2010;5(9):1574–1582. doi: 10.1038/nprot.2010.123
   PubMed Web of Science ®Google Scholar
• Pan S, Aebersold R. Quantitative proteomics by stable isotope labeling and mass spectrometry. Methods Mol Biol. 2007;367:209–218.
   PubMedGoogle Scholar
• Chen X, Sun Y, Zhang T, et al. Quantitative proteomics using isobaric labeling: a practical guide. Int J Geno Prot. 2021;19(5):689–706. doi: 10.1016/j.gpb.2021.08.012
   Google Scholar
• Chu HW, Chang KP, Hsu CW, et al. Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Mol Cell Proteomics. 2019;18(9):1796–1806. doi: 10.1074/mcp.RA119.001530
   PubMed Web of Science ®Google Scholar
• Shan J, Sun Z, Yang J, et al. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas. Oral Dis. 2019;25(1):97–107. doi: 10.1111/odi.12971
   PubMed Web of Science ®Google Scholar
• van Leeuwen SJM, Proctor GB, Staes A, et al. The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach. BMC Oral Health. 2023;23(1):460. doi: 10.1186/s12903-023-03190-w
   PubMed Web of Science ®Google Scholar
• St John MA, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngology–Head & Neck Surgery. 2004;130(8):929–935. doi: 10.1001/archotol.130.8.929
   PubMedGoogle Scholar
• Kumar P, Gupta S, Das BC. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer. Transl Oncol. 2024;40:101827. doi: 10.1016/j.tranon.2023.101827
   PubMed Web of Science ®Google Scholar
• Parker CE, Borchers CH. Mass spectrometry based biomarker discovery, verification, and validation–quality assurance and control of protein biomarker assays. Mol Oncol. 2014;8(4):840–858. doi: 10.1016/j.molonc.2014.03.006
   PubMed Web of Science ®Google Scholar
• Alhajj M, Zubair M, Farhana A. Enzyme Linked Immunosorbent Assay. In: StatPearls. Treasure Island (FL); 2024. https://www.ncbi.nlm.nih.gov/books/NBK555922/
   Google Scholar
• Begum H, Murugesan P, Tangutur A. Western blotting: a powerful staple in scientific and biomedical research. Biotechniques. 2022;73(1):58–69. doi: 10.2144/btn-2022-0003
   PubMed Web of Science ®Google Scholar
• Singh KK, Gupta A, Bharti C, et al. Emerging techniques of western blotting for purification and analysis of protein. Future J Pharm Sci. 2021;7(1):239. doi: 10.1186/s43094-021-00386-1
   Web of Science ®Google Scholar
• Bass JJ, Wilkinson DJ, Rankin D, et al. An overview of technical considerations for Western blotting applications to physiological research. Scandinavian J Med Sci Sports. 2017;27(1):4–25. doi: 10.1111/sms.12702
   PubMed Web of Science ®Google Scholar
• Dunphy K, Dowling P, Bazou D, et al. Current methods of post-translational modification analysis and their applications in blood cancers. Cancers (Basel). 2021;13(8):1930. doi: 10.3390/cancers13081930
   PubMed Web of Science ®Google Scholar
• Ahsan H. Monoplex and multiplex immunoassays: approval, advancements, and alternatives. Comp Clini Pathol. 2022;31(2):333–345. doi: 10.1007/s00580-021-03302-4
   PubMedGoogle Scholar
• Huang Y, Zhu H. Protein Array-based Approaches for Biomarker Discovery in Cancer. Int J Geno Prot. 2017;15(2):73–81. doi: 10.1016/j.gpb.2017.03.001
   Google Scholar
• Fasolo J, Snyder M. Protein microarrays. Methods Mol Biol. 2009;548:209–222.
   PubMedGoogle Scholar
• Honarmand M, Saravani R, Farhad-Mollashahi L, et al. Salivary Lactate Dehydrogenase, C-Reactive Protein, and Cancer Antigen 125 Levels in Patients with oral lichen planus and oral squamous cell carcinoma. International Journal Of Cancer Management. 2021;14(3):e108344. doi: 10.5812/ijcm.108344
   Web of Science ®Google Scholar
• Chang YT, Chu LJ, Liu YC, et al. Verification of saliva matrix metalloproteinase-1 as a strong diagnostic Marker of oral cavity cancer. Cancers (Basel). 2020;12(8):2273. doi: 10.3390/cancers12082273
   PubMed Web of Science ®Google Scholar
• Faria PCB, Carneiro AP, Binato R, et al. Upregulation of tropomyosin alpha-4 chain in patients’ saliva with oral squamous cell carcinoma as demonstrated by phage display. Sci Rep. 2019;9(1):18399. doi: 10.1038/s41598-019-54686-x
   PubMedGoogle Scholar
• Deepthi G, Nandan SR, Kulkarni PG. Salivary tumour necrosis factor-α as a biomarker in oral leukoplakia and oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2019;20(7):2087–2093. doi: 10.31557/APJCP.2019.20.7.2087
   PubMedGoogle Scholar
• van der Merwe L, Wan Y, Cheong HJ, et al. A pilot study to profile salivary angiogenic factors to detect head and neck cancers. BMC Cancer. 2018;18(1):734. doi: 10.1186/s12885-018-4656-3
   PubMedGoogle Scholar
• Peisker A, Raschke GF, Fahmy MD, et al. Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2017;22(3):e270–275. doi: 10.4317/medoral.21626
   PubMed Web of Science ®Google Scholar
• Yu JS, Chen YT, Chiang WF, et al. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proc Natl Acad Sci USA. 2016;113(41):11549–11554. doi: 10.1073/pnas.1612368113
   PubMed Web of Science ®Google Scholar
• Metgud R, Bajaj S. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma. Biotechnic Histochem. 2016;91(2):96–101. doi: 10.3109/10520295.2015.1077393
   PubMed Web of Science ®Google Scholar
• Saluja TS, Spadigam A, Dhupar A, et al. Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype. Tumour Biol. 2016;37(4):5609–5620. doi: 10.1007/s13277-015-4415-x
   PubMedGoogle Scholar
• Giebultowicz J, Wroczynski P, Samolczyk-Wanyura D. Comparison of antioxidant enzymes activity and the concentration of uric acid in the saliva of patients with oral cavity cancer, odontogenic cysts and healthy subjects. J Pathology Med. 2011;40(9):726–730. doi: 10.1111/j.1600-0714.2011.01045.x
   PubMed Web of Science ®Google Scholar
• Brinkmann O, Kastratovic DA, Dimitrijevic MV, et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011;47(1):51–55. doi: 10.1016/j.oraloncology.2010.10.009
   PubMed Web of Science ®Google Scholar
• Arellano-Garcia ME, Hu S, Wang J, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008;14(8):705–712. doi: 10.1111/j.1601-0825.2008.01488.x
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Ho V, Miller CS, et al. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29(1):42–45. doi: 10.1016/j.cdp.2004.10.003
   PubMedGoogle Scholar
• Contucci AM, Inzitari R, Agostino S, et al. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report. Oral Dis. 2005;11(2):95–99. doi: 10.1111/j.1601-0825.2004.01057.x
   PubMed Web of Science ®Google Scholar
• Balicki R, Grabowska SZ, Citko A. Salivary epidermal growth factor in oral cavity cancer. Oral Oncol. 2005;41(1):48–55. doi: 10.1016/j.oraloncology.2004.06.004
   PubMed Web of Science ®Google Scholar
• Korostoff A, Reder L, Masood R, et al. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol. 2011;47(4):282–287. doi: 10.1016/j.oraloncology.2011.02.006
   PubMed Web of Science ®Google Scholar
• Sivadasan P, Gupta MK, Sathe G, et al. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. J Proteomics. 2020;212:103574. doi: 10.1016/j.jprot.2019.103574
   PubMed Web of Science ®Google Scholar
• Hsiao YC, Lin SY, Chien KY, et al. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Anal Chim Acta. 2020;1100:118–130. doi: 10.1016/j.aca.2019.12.006
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Ishizawa K, Tanaka A, et al. Identification of salivary proteomic biomarkers for oral cancer Screening. Vivo (Athens, Greece). 2021;35(1):541–547. doi: 10.21873/invivo.12289
   PubMed Web of Science ®Google Scholar
• Kang Y, Chen J, Li X, et al. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. Cancer Biomark. 2021;31(4):317–328. doi: 10.3233/CBM-203105
   PubMed Web of Science ®Google Scholar
• Nakamichi E, Sakakura H, Mii S, et al. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma. Oral Dis. 2021;27(3):439–447. doi: 10.1111/odi.13565
   PubMed Web of Science ®Google Scholar
• Babiuch K, Kusnierz-Cabala B, Kesek B, et al. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue specimens and saliva of patients with oral squamous cell carcinoma and oral potentially malignant disorders. J Clin Med. 2020;9(3):867. doi: 10.3390/jcm9030867
   PubMed Web of Science ®Google Scholar
• Zielinska K, Karczmarek-Borowska B, Kwasniak K, et al. Salivary IL-17A, IL-17F, and Tnf- α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer. J Immunol Res. 2020;2020:1–8. doi: 10.1155/2020/3928504
   Google Scholar
• Rathore AS, Katyal S, Jain A, et al. Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders. J Cancer Res Ther. 2020;16(3):452–457. doi: 10.4103/jcrt.JCRT_893_17
   PubMed Web of Science ®Google Scholar
• Marton IJ, Horvath J, Labiscsak P, et al. Salivary IL-6 mRNA is a robust biomarker in oral squamous cell carcinoma. J Clin Med. 2019;8(11):1958. doi: 10.3390/jcm8111958
   PubMed Web of Science ®Google Scholar
• Lin YH, Eguez RV, Torralba MG, et al. Self-assembled strap for global proteomics and salivary biomarker discovery. J Proteome Res. 2019;18(4):1907–1915. doi: 10.1021/acs.jproteome.9b00037
   PubMed Web of Science ®Google Scholar
• Feng Y, Li Q, Chen J, et al. Salivary protease spectrum biomarkers of oral cancer. Int J Oral Sci. 2019;11(1):7. doi: 10.1038/s41368-018-0032-z
   PubMedGoogle Scholar
• Janssen EM, Dy SM, Meara AS, et al. Analysis of patient preferences in lung cancer - estimating acceptable tradeoffs between treatment benefit and side effects. Patient Prefer Adherence. 2020;14:927–937. doi: 10.2147/PPA.S235430
   PubMed Web of Science ®Google Scholar
• Zheng J, Sun L, Yuan W, et al. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma. J Oral Pathology Med. 2018;47(9):830–835. doi: 10.1111/jop.12767
   PubMed Web of Science ®Google Scholar
• Lopez-Verdin S, Soto-Avila JJ, Zamora-Perez AL, et al. Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva. Med Oral Patol Oral Cir Bucal. 2017;22(6):e694–e701. doi: 10.4317/medoral.21907
   PubMed Web of Science ®Google Scholar
• Csosz E, Labiscsak P, Kallo G, et al. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers. PLOS ONE. 2017;12(5):e0177282. doi: 10.1371/journal.pone.0177282
   PubMed Web of Science ®Google Scholar
• Zanotti L, Paderno A, Piazza C, et al. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer. Laryngoscope. 2017;127(11):E408–E414. doi: 10.1002/lary.26797
   PubMed Web of Science ®Google Scholar
• Ghallab NA, Shaker OG. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig. 2017;21(3):937–947. doi: 10.1007/s00784-016-1846-8
   PubMed Web of Science ®Google Scholar
• Honarmand MH, Farhad-Mollashahi L, Nakhaee A, et al. Salivary Levels of ErbB2 and CEA in oral squamous cell carcinoma patients. Asian Pac J Cancer Prev. 2016;17(S3):77–80. doi: 10.7314/APJCP.2016.17.S3.77
   PubMedGoogle Scholar
• Malhotra R, Urs AB, Chakravarti A, et al. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol. 2016;37(7):9263–9271. doi: 10.1007/s13277-016-4809-4
   PubMedGoogle Scholar
• Ajona D, Pajares MJ, Chiara MD, et al. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma. Oral Dis. 2015;21(7):899–904. doi: 10.1111/odi.12363
   PubMed Web of Science ®Google Scholar
• Winck FV, Prado Ribeiro AC, Ramos Domingues R, et al. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep. 2015;5(1):16305. doi: 10.1038/srep16305
   PubMedGoogle Scholar
• Rajkumar K, Ramya R, Nandhini G, et al. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis. 2015;21(1):90–96. doi: 10.1111/odi.12216
   PubMed Web of Science ®Google Scholar
• Goncalves AS, Arantes DA, Bernardes VF, et al. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva. Hum Immunol. 2015;76(1):52–58. doi: 10.1016/j.humimm.2014.11.002
   PubMed Web of Science ®Google Scholar
• Patel S, Metgud R. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study. J Cancer Res Ther. 2015;11(1):119–123. doi: 10.4103/0973-1482.138193
   PubMed Web of Science ®Google Scholar
• Varun C, Dineshkumar T, Jayant VS, et al. Salivary Her2/neu levels in differentiation of oral premalignant disorders and oral squamous cell carcinomas. Asian Pac J Cancer Prev. 2015;16(14):5773–5777. doi: 10.7314/APJCP.2015.16.14.5773
   PubMedGoogle Scholar
• Arduino PG, Menegatti E, Cappello N, et al. Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. Int J Biol Markers. 2015;30(2):e262–266. doi: 10.5301/jbm.5000142
   PubMed Web of Science ®Google Scholar
• Hsu CW, Yu JS, Peng PH, et al. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma. J Proteome Res. 2014;13(11):4796–4807. doi: 10.1021/pr500038k
   PubMed Web of Science ®Google Scholar
• Jou YJ, Hua CH, Lin CD, et al. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS. Clin Chim Acta. 2014;436:121–129. doi: 10.1016/j.cca.2014.05.009
   PubMed Web of Science ®Google Scholar
• Mu AK, Chan YS, Kang SS, et al. Detection of host-specific immunogenic proteins in the saliva of patients with oral squamous cell carcinoma. J Immunoassay Immunochem. 2014;35(2):183–193. doi: 10.1080/15321819.2013.836535
   PubMedGoogle Scholar
• Jessie K, Jayapalan JJ, Rahim ZH, et al. Aberrant proteins featured in the saliva of habitual betel quid chewers: an indication of early oral premalignancy? Electrophoresis. 2014;35(24):3504–3511. doi: 10.1002/elps.201400252
   PubMed Web of Science ®Google Scholar
• Chaiyarit P, Utrawichian A, Leelayuwat C, et al. Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma. Clin Oral Investig. 2012;16(6):1549–1556. doi: 10.1007/s00784-011-0667-z
   PubMed Web of Science ®Google Scholar
• Szanto I, Mark L, Bona A, et al. High-throughput screening of saliva for early detection of oral cancer: a pilot study. Technol Cancer Res Treat. 2012;11(2):181–188. doi: 10.7785/tcrt.2012.500248
   PubMed Web of Science ®Google Scholar
• Sartini D, Pozzi V, Renzi E, et al. Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol Chem. 2012;393(6):505–511. doi: 10.1515/hsz-2012-0112
   PubMed Web of Science ®Google Scholar
• Stott-Miller M, Houck JR, Lohavanichbutr P, et al. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Preven. 2011;20(12):2628–2636. doi: 10.1158/1055-9965.EPI-11-0503
   PubMed Web of Science ®Google Scholar
• Jou YJ, Lin CD, Lai CH, et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta. 2011;412(15–16):1357–1365. doi: 10.1016/j.cca.2011.04.004
   PubMed Web of Science ®Google Scholar
• Shintani S, Hamakawa H, Ueyama Y, et al. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofacial Surg. 2010;39(1):68–74. doi: 10.1016/j.ijom.2009.10.001
   PubMed Web of Science ®Google Scholar
• Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14(19):6246–6252. doi: 10.1158/1078-0432.CCR-07-5037
   PubMed Web of Science ®Google Scholar
• Pickering V, Jordan RC, Schmidt BL. Elevated salivary endothelin levels in oral cancer patients–a pilot study. Oral Oncol. 2007;43(1):37–41. doi: 10.1016/j.oraloncology.2005.12.027
   PubMed Web of Science ®Google Scholar
• Zhong LP, Zhang CP, Zheng JW, et al. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol. 2007;52(11):1079–1087. doi: 10.1016/j.archoralbio.2007.05.005
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Cheng B, Myers S, et al. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog. 2005;44(2):77–82. doi: 10.1002/mc.20113
   PubMed Web of Science ®Google Scholar
• Xie H, Onsongo G, Popko J, et al. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics. 2008;7(3):486–498. doi: 10.1074/mcp.M700146-MCP200
   PubMed Web of Science ®Google Scholar
• Xiao H, Zhang Y, Kim Y, et al. Differential proteomic analysis of human saliva using tandem Mass tags quantification for gastric cancer detection. Sci Rep. 2016;6(1):22165. doi: 10.1038/srep22165
   PubMedGoogle Scholar
• Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLOS ONE. 2010;5(12):e15004. doi: 10.1371/journal.pone.0015004
   PubMed Web of Science ®Google Scholar
• Wang K, Shen Y, Xu J, et al. Evaluation of synuclein-gamma levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients. Neoplasma. 2020;67(3):707–713. doi: 10.4149/neo_2020_190619N523
   PubMed Web of Science ®Google Scholar
• Kawahara R, Bollinger JG, Rivera C, et al. A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva. Proteomics. 2016;16(1):159–173. doi: 10.1002/pmic.201500224
   PubMed Web of Science ®Google Scholar
• Nosratzehi F, Nosratzehi T, Alijani E, et al. Salivary beta2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma. BMC Res Notes. 2020;13(1):294. doi: 10.1186/s13104-020-05135-w
   PubMed Web of Science ®Google Scholar
• Singh P, Verma JK, Singh JK. Validation of salivary markers, IL-1beta, IL-8 and Lgals3bp for detection of oral squamous cell carcinoma in an Indian population. Sci Rep. 2020;10(1):7365. doi: 10.1038/s41598-020-64494-3
   PubMed Web of Science ®Google Scholar
• Bernardes VF, Gleber-Netto FO, Sousa SF, et al. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study. J Exp Clin Cancer Res. 2010;29(1):40. doi: 10.1186/1756-9966-29-40
   PubMedGoogle Scholar
• Sabarathinam J, Selvaraj J, Devi S. Estimation of levels of glutathione peroxidase (gpx), malondialdehyde (mda), tumor necrosis factor alpha (Tnf Alpha) and alpha feto protein (Afp) in saliva of potentially malignant disorders and oral squamous cell carcinoma. Biomed Pharm J. 2019;12(4):1881–1886. doi: 10.13005/bpj/1818
   Google Scholar
• Smriti K, Ray M, Chatterjee T, et al. Salivary MMP-9 as a biomarker for the diagnosis of oral potentially malignant disorders and oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2020;21(1):233–238. doi: 10.31557/APJCP.2020.21.1.233
   PubMedGoogle Scholar
• Csosz E, Markus B, Darula Z, et al. Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population. FEBS Open Bio. 2018;8(4):556–569. doi: 10.1002/2211-5463.12391
   PubMed Web of Science ®Google Scholar
• Cai M, Zheng Z, Bai Z, et al. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. BMC Cancer. 2022;22(1):530. doi: 10.1186/s12885-022-09630-0
   PubMed Web of Science ®Google Scholar
• Geng XF, Du M, Han JX, et al. Saliva CA125 and TPS levels in patients with oral squamous cell carcinoma. Int J Biol Markers. 2013;28(2):216–220. doi: 10.5301/jbm.5000001
   PubMed Web of Science ®Google Scholar
• Lisa Cheng YS, Jordan L, Gorugantula LM, et al. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases. J Periodontol. 2014;85(7):956–965. doi: 10.1902/jop.2013.130320
   PubMed Web of Science ®Google Scholar
• Vajaria BN, Patel KR, Begum R, et al. Salivary glyco-sialylation changes monitors oral carcinogenesis. Glycoconj J. 2014;31(9):649–659. doi: 10.1007/s10719-014-9561-7
   PubMed Web of Science ®Google Scholar
• Aziz S, Ahmed SS, Ali A, et al. Salivary Immunosuppressive Cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest. 2015;33(7):318–328. doi: 10.3109/07357907.2015.1041642
   PubMed Web of Science ®Google Scholar
• Krapfenbauer K, Drucker E, Thurnher D. Identification of tumour-related proteins as potential screening markers by proteome analysis-protein profiles of human saliva as a predictive and prognostic tool. EPMA Journal. 2014;5(1):20. doi: 10.1186/1878-5085-5-20
   PubMedGoogle Scholar
• Li SX, Yang YQ, Jin LJ, et al. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients. Cancer Biomark. 2016;17(4):377–382. doi: 10.3233/CBM-160651
   PubMed Web of Science ®Google Scholar
• Chianeh YR, Manjunath R, Prabhu K, et al. Protein thiols and butyrylcholinesterase in saliva of oral cancer patients. Indian J Clin Biochem. 2014;29(2):238–241. doi: 10.1007/s12291-013-0352-x
   PubMedGoogle Scholar
• Vajaria BN, Patel KR, Begum R, et al. Evaluation of serum and salivary total sialic acid and alpha-l-fucosidase in patients with oral precancerous conditions and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(6):764–771. doi: 10.1016/j.oooo.2013.01.004
   PubMed Web of Science ®Google Scholar
• Ko HH, Peng HH, Cheng SJ, et al. Increased salivary AKR1B10 level: association with progression and poor prognosis of oral squamous cell carcinoma. Head & Neck. 2018;40(12):2642–2647. doi: 10.1002/hed.25370
   PubMed Web of Science ®Google Scholar
• Seyedmajidi S, Seyedmajidi M, Foroughi R, et al. Comparison of salivary and serum soluble CD44 levels between patients with oral scc and healthy controls. Asian Pac J Cancer Prev. 2018;19(11):3059–3063. doi: 10.31557/APJCP.2018.19.11.3059
   PubMedGoogle Scholar
• Heawchaiyaphum C, Pientong C, Phusingha P, et al. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches. J Proteomics. 2018;173:52–61. doi: 10.1016/j.jprot.2017.11.022
   PubMed Web of Science ®Google Scholar
• Jou YJ, Lin CD, Lai CH, et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta. 2010;681(1–2):41–48. doi: 10.1016/j.aca.2010.09.030
   PubMed Web of Science ®Google Scholar
• Gholizadeh N, Mohebbi AH, Mirzaii-Dizgah I, et al. α1 adrenergic receptors in serum and saliva of patients with oral squamous cell carcinoma. Clin Transl Oncol. 2021;23(8):1705–1710. doi: 10.1007/s12094-021-02571-3
   PubMed Web of Science ®Google Scholar
• Shpitzer T, Hamzany Y, Bahar G, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer. 2009;101(7):1194–1198. doi: 10.1038/sj.bjc.6605290
   PubMed Web of Science ®Google Scholar
• Gleber-Netto FO, Yakob M, Li F, et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016;22(13):3340–3347. doi: 10.1158/1078-0432.CCR-15-1761
   PubMed Web of Science ®Google Scholar
• Sato J, Ohuchi M, Abe K, et al. Correlation between salivary interleukin-6 levels and early locoregional recurrence in patients with oral squamous cell carcinoma: preliminary study. Head Neck. 2013;35(6):889–894. doi: 10.1002/hed.23056
   PubMed Web of Science ®Google Scholar
• Wu CC, Chang YT, Chang KP, et al. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol Biomarker Prevent. 2014;23(8):1569–1578. doi: 10.1158/1055-9965.EPI-13-1269
   PubMed Web of Science ®Google Scholar
• Rai AK, Panda M, Das AK, et al. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 2021;203(1):137–152. doi: 10.1007/s00203-020-02011-w
   PubMed Web of Science ®Google Scholar
• Schork K, Podwojski K, Turewicz M, et al. Important issues in planning a proteomics experiment: statistical considerations of quantitative proteomic data. Methods Mol Biol. 2021;2228:1–20.
   PubMedGoogle Scholar
• Voss H, Schlumbohm S, Barwikowski P, et al. HarmonizR enables data harmonization across independent proteomic datasets with appropriate handling of missing values. Nat Commun. 2022;13(1):3523. doi: 10.1038/s41467-022-31007-x
   PubMed Web of Science ®Google Scholar
• Wik L, Nordberg N, Broberg J, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021;20:100168. doi: 10.1016/j.mcpro.2021.100168
   PubMedGoogle Scholar
• Kraemer S, Vaught JD, Bock C, et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLOS ONE. 2011;6(10):e26332. doi: 10.1371/journal.pone.0026332
   PubMed Web of Science ®Google Scholar
• Bourmaud A, Gallien S, Domon B. A quality control of proteomic experiments based on multiple isotopologous internal standards. EuPA Open Proteom. 2015;8:16–21. doi: 10.1016/j.euprot.2015.07.010
   Google Scholar
• Zhou C, Simpson KL, Lancashire LJ, et al. Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery. J Proteome Res. 2012;11(4):2103–2113. doi: 10.1021/pr200636x
   PubMed Web of Science ®Google Scholar
• Serdar CC, Cihan M, Yucel D, et al. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem med (Online). 2021;31(1):27–53. doi: 10.11613/BM.2021.010502
   Web of Science ®Google Scholar
• Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Informat. 2014;48:193–204. doi: 10.1016/j.jbi.2014.02.013
   PubMed Web of Science ®Google Scholar
• Andrade C. Sample size and its importance in research. Indian J Psychol Med. 2020;42(1):102–103. doi: 10.4103/IJPSYM.IJPSYM_504_19
   PubMedGoogle Scholar
• Gumpili SP, Das AV. Sample size and its evolution in research. IHOPE Journal Of Ophthalmology. 2022;1:9–13. doi: 10.25259/IHOPEJO_3_2021
   Google Scholar
• Magaki S, Hojat SA, Wei B, et al. An Introduction to the Performance of Immunohistochemistry. Methods Mol Biol. 2019;1897:289–298.
   PubMedGoogle Scholar
• Matos LL, Trufelli DC, de Matos MG, et al. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20. doi: 10.4137/BMI.S2185
   PubMedGoogle Scholar
• Gupta R, Kurc T, Sharma A, et al. The emergence of Pathomics. Curr Pathobiol Rep. 2019;7(3):73–84. doi: 10.1007/s40139-019-00200-x
   Google Scholar
• Bankhead P, Loughrey MB, Fernandez JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. doi: 10.1038/s41598-017-17204-5
   PubMedGoogle Scholar
• Normando AGC, Dos Santos ES, Sa JO, et al. A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia. Front Oral Health. 2023;4:1088022. doi: 10.3389/froh.2023.1088022
   PubMedGoogle Scholar
• Arroyo E, Donis SP, Petronacci CMC, et al. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis. Cancer Biomark. 2021;32(4):411–424. doi: 10.3233/CBM-203043
   PubMed Web of Science ®Google Scholar
• Piyarathne NS, Rasnayake R, Angammana R, et al. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - a systematic review. Expert Rev Mol Diagn. 2021;21(8):789–807. doi: 10.1080/14737159.2021.1944106
   PubMed Web of Science ®Google Scholar
• Chiamulera MMA, Zancan CB, Remor AP, et al. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):205. doi: 10.1186/s12885-021-07932-3
   PubMed Web of Science ®Google Scholar
• Iglesias-Velazquez O, Lopez-Pintor RM, Gonzalez-Serrano J, et al. Salivary LDH in oral cancer and potentially malignant disorders: a systematic review and meta-analysis. Oral Dis. 2022;28(1):44–56. doi: 10.1111/odi.13630
   PubMed Web of Science ®Google Scholar
• Sa JO, Trino LD, Oliveira AK, et al. Proteomic approaches to assist in diagnosis and prognosis of oral cancer. Expert Rev Proteomics. 2021;18(4):261–284. doi: 10.1080/14789450.2021.1924685
   PubMed Web of Science ®Google Scholar
• Amenabar JM, Da Silva BM, Punyadeera C. Salivary protein biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2020;20(3):305–313. doi: 10.1080/14737159.2020.1722102
   PubMed Web of Science ®Google Scholar
• Benito-Ramal E, Egido-Moreno S, Gonzalez-Navarro B, et al. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28(5):e474–e486. doi: 10.4317/medoral.25889
   PubMed Web of Science ®Google Scholar
• Hema Shree K, Ramani P, Sherlin H, et al. Saliva as a diagnostic tool in oral squamous cell carcinoma – a systematic review with meta analysis. Pathol Oncol Res. 2019;25(2):447–453. doi: 10.1007/s12253-019-00588-2
   PubMed Web of Science ®Google Scholar
• AlAli AM, Walsh T, Maranzano M. CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy. Int J Oral Maxillofacial Surg. 2020;49(8):973–983. doi: 10.1016/j.ijom.2020.01.020
   PubMed Web of Science ®Google Scholar